当前位置:主页 > 医学论文 > 中医论文 >

自拟益肾健脾化瘀方治疗绝经后脾肾阳虚型骨质疏松症的临床研究

发布时间:2018-11-03 17:10
【摘要】:目的探讨自拟益肾健脾化瘀方治疗绝经后脾肾阳虚型骨质疏松症的临床疗效。方法选取2016年1月-2017年1月我院收治的120例绝经后骨质疏松症患者,将其按照随机数字法随机分为观察组和对照组,每组60例,2组均给予碳酸钙D3片,在此基础上,对照组给予仙灵骨葆胶囊,观察组给予自拟益肾健脾化瘀方剂,2组均治疗3月。结果治疗后2组腰背疼痛、腰膝酸软、夜尿增加、畏寒肢冷、神疲倦怠及总评分均显著下降(P0.01),但观察组下降更为明显(P0.01);治疗后观察组总有效率为93.33%,显著高于对照组(80.00%,P0.01);2组腰椎L2~L4、股骨颈、股骨大转子、Ward's三角骨密度均较治疗前显著增加(P0.01),但观察组增加更为明显(P0.01);2组骨特异性碱性磷酸酶(B-ALP)、抗酒石酸酸性磷酸酶(TRACP)均较治疗前显著下降(P0.01),观察组下降更为明显(P0.01);2组雌二醇(E2)、胰岛素生长因子(IGF-1)均较治疗前显著上升(P0.01),观察组上升更为明显(P0.01);2组患者不良反应发生率比较差异无统计学意义(P0.05)。结论采用自拟益肾健脾化瘀方可以显著改善绝经后脾肾阳虚型骨质疏松症的临床症状,同时可改善患者骨代谢和骨密度,其作用机制可能与提高雌激素和IGF-1水平有关。
[Abstract]:Objective to investigate the clinical effect of Yishen Jianpi Huayu recipe in treating postmenopausal osteoporosis with deficiency of spleen and kidney yang. Methods 120 postmenopausal osteoporosis patients admitted to our hospital from January 2016 to January 2017 were randomly divided into observation group (n = 60) and control group (n = 60). The control group was treated with Xianling Gu Bao capsule, the observation group with self-made prescription of tonifying kidney and spleen and removing blood stasis, and the two groups were treated for 3 months. Results after treatment, the pain of the back of the waist, the weakness of the waist and knee, the increase of nocturnal urine, the chills of the cold limbs, the burnout of the cold limbs and the total score of the two groups were significantly decreased (P0.01), but the decrease was more obvious in the observation group (P0.01). The total effective rate of the observation group was 93.33, which was significantly higher than that of the control group (80.00g / P0.01). The bone mineral density of L2P L4, femoral neck, greater trochanter of femur and Ward's triangle in both groups were significantly higher than those before treatment (P0.01), but the increase in observation group was more obvious (P0.01). Bone specific alkaline phosphatase (B-ALP) and tartrate-resistant acid phosphatase (TRACP) were significantly decreased in both groups (P0.01), especially in the observation group (P0.01). The levels of estradiol (E2) and insulin growth factor (IGF-1) in both groups were significantly higher than those before treatment (P0.01), especially in the observation group (P0.01). There was no significant difference in the incidence of adverse reactions between the two groups (P0.05). Conclusion the self-made prescription of tonifying spleen and removing blood stasis can significantly improve the clinical symptoms of osteoporosis with deficiency of spleen and kidney yang after menopause, as well as improve bone metabolism and bone mineral density. The mechanism may be related to the increase of estrogen and IGF-1 levels.
【作者单位】: 江西省妇幼保健院妇科;江西省妇幼保健院病理科;
【基金】:江西省卫计委科技计划课题(20165443)
【分类号】:R259

【相似文献】

相关期刊论文 前10条

1 王燕,余杨桂,李志英,张细芝;滋肾健脾化瘀方联合激光治疗糖尿病视网膜病变的临床观察[J];中国中医眼科杂志;2000年03期

2 田垒,刘大跃,耿跃春,张斌;健脾化瘀方防治胃癌前期病变实验研究[J];中成药;2002年05期

3 赵江;王瑞平;邹玺;;健脾化瘀方对人肝癌细胞SMMC-7721增殖和凋亡的影响[J];实用中医内科杂志;2009年11期

4 沈均;高书荣;梁爱宝;;补肾健脾化瘀方治疗2型糖尿病Ou非酒精性脂肪肝病的临床研究[J];中国中西医结合消化杂志;2012年07期

5 刘承琴,赵建群;滋肾健脾化瘀方治疗早期糖尿病肾病41例[J];山东中医杂志;2003年11期

6 魏秋实;邓伟民;王海彬;孙伟珊;霍少川;邵玉;谭新;;补肾健脾化瘀方对去势骨质疏松大鼠血液流变学指标的影响[J];中华中医药杂志;2014年02期

7 韩涛;杨少军;兰咏梅;王佳蕾;;健脾化瘀方治疗溃疡性结肠炎32例临床研究[J];新中医;2009年02期

8 肖建欣;;健脾化瘀方治疗高胆红素血症112例临床观察[J];中国卫生产业;2012年24期

9 邹玺;王瑞平;赵江;;健脾化瘀方对人肝癌细胞ras/MAPK通路的影响[J];右江医学;2009年05期

10 杨红蓉;郭培京;张娜;于斌;杨青峰;韩俊丽;肖晶;;健脾化瘀方治疗腹型过敏性紫癜89例临床观察[J];中医杂志;2013年06期

相关会议论文 前1条

1 余杨桂;王燕;王小川;易细香;;滋肾健脾化瘀方治疗糖尿病性视网膜病变的疗效及机制[A];中国眼底病论坛·全国眼底病专题学术研讨会论文汇编[C];2008年

相关博士学位论文 前1条

1 王小川;滋肾健脾化瘀方治疗早期糖尿病视网膜病变的临床与实验研究[D];广州中医药大学;2005年

相关硕士学位论文 前4条

1 郭苇;健脾化瘀方通过miRNA-570对B7-H1/PD-1通路的调控促进肝癌休眠[D];广州中医药大学;2016年

2 赵江;健脾化瘀方治疗原发性肝癌的实验研究[D];南京中医药大学;2009年

3 黄旭晖;健脾化瘀方促进小鼠肝癌休眠的机制研究[D];广州中医药大学;2013年

4 张细芝;滋肾健脾化瘀方防治糖尿病视网膜病变研究[D];广州中医药大学;2000年



本文编号:2308411

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2308411.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户f83c8***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com